HK Stock Market Move | MEDBOT-B (02252) rises by more than 7% Medical equipment welcomes good news The company has completed a new round of private placement before

MEDBOT-B(02252) rose more than 7%, as of the time of writing, it increased by 6.85% to HKD 9.83, with a turnover of 1.21 billion Hong Kong dollars. On the news front, the State Council has increased its support for the research and development innovation of pharmaceuticals and medical devices, improving the efficacy of drug and medical device review and approval, and allocating more review and approval resources to key innovative drugs and medical devices urgently needed in clinical settings. According to a report by Zhongjin Research, despite the continued rectification of the medical industry, slow progress in equipment procurement, and the impact of factors such as IVD and high-consumption procurement, medical device listed companies have experienced performance disturbances in recent quarters. However, we have also observed that the marginal impact of these factors is gradually weakening or improving, and the sub-sectors of the medical device sector may benefit from product upgrades and overseas exports by 2025. Microport Siasun Robot&Automation recently completed a new round of placements, raising a net amount of approximately 266 million Hong Kong dollars. Southwest previously stated that the company is strengthening its focus on the business of endoscopy and orthopedics with Siasun Robot&Automation, achieving success both domestically and internationally. In the first half of 2024, the company's net loss was 28 million yuan, a year-on-year decrease of 48.6%, with a net outflow of free cash flow of 240 million yuan (-49.7%), mainly due to the company's implementation of cost reduction and efficiency enhancement and business focus development strategies in 2023, efficient cash flow control measures, optimization of product costs, and focus on core businesses such as endoscopy for commercialization and sales, which is beneficial for the company's medium- and long-term healthy and steady development.